Bernard Hoet | Vice President of Medical Strategy
Bavarian Nordic A/S

Bernard Hoet is Vice President, Head of Medical strategy at Bavarian Nordic, a fully integrated pure-play vaccine company. He joined this company early 2020, at the time of acquisition of the rabies and tick-born encephalitis vaccines from GSK, to build up the Medical Affairs department, and rapidly also created the Epidemiology department and then took care of the Clinical Development Strategy department and integrated the Medical Writing department of this company. The mpox outbreak of 2022, the launch of a chikungunya vaccine, and the current mpox outbreak are his main focus activities today, in addition to the development of Bavarian Nordic’s pipeline. Bernard in an MD, FFPM with decades of experience in vaccines Medical Affairs, Pharmacovigilance, Clinical Development, Labeling and Quality Assurance, and has preformed pre-clinical and clinical research previously